Annovis Bio Inc (ANVS)

07:08 AM

Annovis Bio completes enrollment in phase 3 Alzheimer’s trial - Investing.com

07:08 AM

07:00 AM

Annovis enrolls 850 patients in Phase 3 Alzheimer’s study - Stock Titan

07:00 AM

Jul 04, 2026

The buntanetap programAnnovis Bio bets on neurodegeneration trials - AD HOC NEWS

Jul 04, 2026

Jul 01, 2026

Annovis Bio promotes Cheng Fang to chief scientific officer - Investing.com

Jul 01, 2026

Jul 01, 2026

Annovis Bio Promotes Cheng Fang to Chief Scientific Officer Ahead of Phase 3 Milestones - citybiz

Jul 01, 2026

Jul 01, 2026

Annovis Bio promotes Cheng Fang to chief scientific officer By Investing.com - Investing.com Canada

Jul 01, 2026

Jul 01, 2026

Press Release: Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer - Moomoo

Jul 01, 2026

Jul 01, 2026

Annovis elevates its R&D chief as Phase 3 Alzheimer’s data nears - Stock Titan

Jul 01, 2026

Jun 30, 2026

ANVSAnnovis Bio Inc Latest SEC Filings - Finviz

Jun 30, 2026

Jun 29, 2026

ANVS Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineAnalyst Consensus Shift - dars.gov.et

Jun 29, 2026

Jun 29, 2026

Annovis Bio, Inc.(NYSE: ANVS) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Annovis Bio, Inc.(NYSE: ANVS) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Annovis Bio, Inc.(NYSE: ANVS) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

ANVS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 28, 2026

Jun 28, 2026

Annovis Bio, Inc.(NYSE: ANVS) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Annovis Bio (ANVS) Shows Resilience With 4.24% Gain, Testing Key ResistanceBeta Neutral Pair - dars.gov.et

Jun 27, 2026

Jun 27, 2026

Annovis Bio | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jun 27, 2026

Jun 26, 2026

Annovis Bio Inc Actuals & Estimates (TRADEGATE:07X) - TradingView

Jun 26, 2026

Jun 26, 2026

Annovis Bio | DEFA14A: Others - Moomoo

Jun 26, 2026

Jun 26, 2026

ANVS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Annovis Bio Inc Actuals & Estimates (FWB:07X) - TradingView

Jun 26, 2026

Jun 26, 2026

07X Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBITDA forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 25, 2026

Price to sales forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 25, 2026

Enterprise value to revenue forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 21, 2026

Annovis Bio Inc (ANVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 21, 2026

Jun 18, 2026

Annovis Bio Shareholders Approve Governance and Compensation Changes - The Globe and Mail

Jun 18, 2026

Jun 18, 2026

Why Annovis’ buntanetap pill is drawing fresh attention in Alzheimer’s race - AD HOC NEWS

Jun 18, 2026

Jun 18, 2026

Annovis Bio Inc (ANVS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026

Jun 17, 2026

Annovis Bio shareholders approve all proposals at annual meeting - Investing.com UK

Jun 17, 2026

Jun 17, 2026

Annovis Bio shareholders approve all proposals at annual meeting By Investing.com - Investing.com India

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio (NYSE: ANVS) holders expand equity plan and set biennial say-on-pay - Stock Titan

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 14, 2026

Press Release: Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - 富途牛牛

Jun 14, 2026

Jun 10, 2026

Annovis Bio Inc Stock (US0360431013): Short Interest Climbs At End Of May - AD HOC NEWS

Jun 10, 2026

Jun 05, 2026

Annovis Bio Price, ANVS Price, Live Charts, and Marketcap - Coinbase

Jun 05, 2026

Jun 03, 2026

Annovis Regains NYSE Compliance Ahead of Listing Deadline - MyChesCo

Jun 03, 2026

May 29, 2026

Maxim Group Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 29, 2026

May 26, 2026

Annovis Bio (ANVS) Faces Selling Pressure: Key Levels in Focus After 7.6% DeclineVolume Rate Change - thelegaladvocate.com

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance - MSN

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance By Investing.com - Investing.com Nigeria

May 26, 2026

May 26, 2026

Annovis Bio Regains NYSE Listing Compliance - The Manila Times

May 26, 2026

May 23, 2026

Annovis launches proposed public stock and warrant offering - MSN

May 23, 2026

May 22, 2026

Annovis Bio Analyst Ratings and Price Targets | NYSE:ANVS - Benzinga

May 22, 2026